Acute respiratory distress syndrome (ARDS) is present in >10% of all people admitted to critical care and is associated with severe morbidity and mortality. Despite more than half a century since its ...
In April 2024, mavorixafor received U.S. Food and Drug Administration approval as XOLREMDI ®, an oral, once-daily treatment for use in patients 12 years of age and older with WHIM syndrome to increase ...
Intermediate ILC2s share traits of both ILC2s and another type of immune cell called group 3 innate lymphoid cells, or ILC3s. ILC3s are tied to another type of white blood cell called neutrophils. An ...
State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan ...